ImmuCell Corporation (ICCC)
Makes products that prevent disease in dairy and beef cattle.
$11.24+0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+87.3%
The outlook
ImmuCell trades at $11.24, sitting well above both its 50- and 200-day moving averages and positioned near the upper end of its 52-week range. The stock's current positioning reflects strength in its recent trend, though analyst coverage appears limited on this smaller-cap name.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range89% of the way from its 52-week low to high
Market cap
$101.7M
52-wk high
$12.10
52-wk low
$4.52
50-day avg
$10.20
200-day avg
$7.40
Trailing P/E
—